Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 3, 2005, Pages 314-321

  Hernandez Pampaloni, Miguel ^a   Bax, Jeroen J ^b   Morita, Koichi ^a   Dutka, David P ^a   Camici, Paolo G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac imaging; Coronary artery disease; Hibernation; Myocardial ischaemia; Stunning

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE UTILIZATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE CONTRACTILITY; HUMAN; HYPERINSULINEMIA; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; STUNNED HEART MUSCLE;

CARDIOMYOPATHIES; CHRONIC DISEASE; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 17644393124     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1682-y     Document Type: Article

References (40)

1. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
2. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30:1451-60.
3. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998;116:997-1004.
4. Pagano D, Townend JN, Littler WA, Horton R, Camici PG, Bonser RS. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791-9.
5. Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693-700.
6. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahintoola SH. Sensitivity, specificity and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:146-86.
7. 13N-ammonia myocardial blood flow and uptake. Relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol 1999;33:678-86.
8. 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation 1999;99:2798-805.
9. Gerber BL, Vanoverschelde JLJ, Bol A, Michel C, Labar D, Wijns W, Melin JA. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996; 94:651-9.
10. Marinho NVS, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737-44.
11. Maki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki LM, Ruotsalainen U, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996; 93:1658-66.
12. Hashimoto K, Nishimura T, Ishikawa M, Koga K, Mori T, Matsuda S, et al. Enhancement of glucose uptake in stunned myocardium: role of glucose transporter. Am J Physiol Heart Circ Physiol 1997;272:H1122-30.
13. Fallavolita JA, Trojan C, Canty JM. Transmural distribution of FDG uptake in stunned myocardium. Am J Physiol Heart Circ Physiol 2000;279:H102-9.
14. Perrone-Filardi P, Bacharach SL, Dilsizian V, Marin-Neto JA, Maurea S, Arrighi JA, Bonow RO. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:608-16.
15. Yamagishi H, Akioka K, Hirata K, Sakanoue Y, Takeuchi K, Yoshikawa J, Ochi H. A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med 1999;40:1492-8.
16. Mesotten L, Maes A, Herregods MC, Desmet W, Nuyts J. Van de Werf F, Mortelmans L. PET "reversed mismatch pattern" early after acute myocardial infarction: follow-up of flow, metabolism and function. Eur J Nucl Med 2001; 28:466-71.
17. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography; American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
18. Spinks TJ, Jones T, Gilardi MC, Heather JD. Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci 1998;35:721-25.
19. De Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738-42.
20. Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, Iida H, Rechavia E, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labelled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875-85.
21. Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA. Measurement of myocardial blood flow with oxygen-15-labelled water: comparison of different administration protocols. Eur J Nucl Med 1998; 25:751-9.
22. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
23. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001;50:151-61.
24. Fath-Ordoubadi F, Beatt KJ, Spyrou N, Camici PG. Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart 1999;82:210-6.
25. 18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging 2002;29:203-15.
26. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
27. Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
28. Knuuti J, Schelbert HR, Bax J. The need for standardization of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2002;29:1257-66.
29. Schelbert HR. Measurements of myocardial metabolism in patients with ischemic heart disease. Am J Cardiol 1998; 82:61K-7K.
30. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994; 90:735-45.
31. Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000;83:456-61.
32. 15O]water techniques. Circulation 1996;93(11):2000-6.
33. Camici PG, Spinks TJ. Advance imaging-PET. In: de Bono DSE editor. Challenges in acute coronary syndromes. Oxford: Blackwell; 1998. pp 148-72.
34. 2 and positron emission tomography: comparison of tracer models. Clin Phys Physiol Meas 1992;13(1):1-20.
35. Camici PG, Rimoldi O. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res 2003;57(2):302-11.
36. McFalls EO, Baldwin D, Palmer B, Marx D, Jaimes D, Ward HB. Regional glucose uptake within hypoperfused swine myocardium as measured by positron emission tomography. Am J Physiol Heart Circ Physiol 1997;272:H343-9.
37. Mills I, Fallon JT, Wrenn D, Sasken H, Gray W, Bier J, et al. Adaptative responses of coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol Heart Circ Physiol 1994;266:H447-57.
38. Fallavolita JA, Malm BJ, Canty JN Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 2003;92:48-55.
39. Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996; 98(9):2094-9.
40. lozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002;51(10):3020-4.